AzTrials
AzTrials

Sclerotic DentineNCT05211908

Clinical Performance of Different Adhesive Strategies With a Universal System in Sclerosed Dentin in NCCL: A Double-blind Randomized Clinical Trial.

A study testing Composite resin restoration with Self Etch adhesive protocol and absence of sclerotic dentin, Composite resin restoration with Seletive enamel etch adhesive protocol and absence of sclerotic dentin and Composite resin restoration with Self Etch adhesive protocol and presence of sclerotic dentin in people with Sclerotic Dentine and Non Carious Cervical Lesion, run by Universidade Federal do Para at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this randomized, prospective, parallel, double-blind clinical trial will be to evaluate the clinical performance of restorations performed in non-carious cervical lesions (NCCL) using a soft ph universal adhesive system, varying the adhesive strategy (self-etching vs. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Composite resin restoration with Self Etch adhesive protocol and absence of sclerotic dentin, Composite resin restoration with Seletive enamel etch adhesive protocol and absence of sclerotic dentin and Composite resin restoration with Self Etch adhesive protocol and presence of sclerotic dentin
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteBrazil
Study dates
27 Jul 2021to 30 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Good general health status
  • Good oral hygiene
  • Absence of periodontal disease
  • Minimum of 20 teeth in occlusion
  • Presence at least one (01) non-carious cervical lesion in a tooth with pulp vitality.
  • Non-carious cervical lesion greater than 1mm in depth.
  • Non-carious cervical lesion involving enamel and dentin.

Who cannot join

  • Non- carious cervical lesion cavo surface margin involving more than 50% of the enamel.
  • NCCL in crack teeth.
  • Absence of opposing teeth and/or adjacent to the lesion.
  • Presence of occlusal trauma in the NCCL tooth
  • Presence of orthodontic appliance or removable partial denture with retention in the tooth where the lesion is located
  • Patients that underwent tooth whitening procedures within a period of less than 14 days from the date of restoration
Show all 11Show fewer
  • Patients with high risk of caries (presence of three or more active caries lesions)
  • Xerostomia
  • Bruxism
  • Pregnant women
  • Patients who do not accept the study conditions

Trial locations and contacts

1 site in 1 country.

Thaís AF Barros, PhD student contact

(91) 98141-8583 ext. 55

thaisa_fig@hotmail.com

Brazil1 site, 1 recruiting
  • Universidade Federal do Pará

    Belém, Pará

    Cecy M Silva, PhD, (91)32017563 ext. 55, cecymsilva@gmail.com

    Recruiting

Other trials in Brazil

About this study

The aim of this randomized, prospective, parallel, double-blind clinical trial will be to evaluate the clinical performance of restorations performed in non-carious cervical lesions (NCCL) using a soft ph universal adhesive system, varying the adhesive strategy (self-etching vs. selective etching of the enamel) and the sclerosis characteristics of the dentinal substrate over 24 months.

Read the detailed description

Two hundred restorations will be performed in NCCL of volunteers of both genders, by a single operator, using the Single Bond Universal(3M ESPE) adhesive system. The restorations will be randomly allocated into 4 groups (n-50): D-SE (absence of dentinal sclerosis and self-etching protocol); D-SELETIVE (absence of dentinal sclerosis and selective enamel etching protocol); SD-SE (sclerotic dentin and self-etching protocol); SD-SELETIVE (sclerotic dentin and selective enamel etching protocol). The randomization process within subject was performed by computer-generated tables by a staff member not involved in the research protocol. Details of the allocated group were recorded on cards contained in sequentially numbered, opaque, sealed envelopes. These were prepared by a staff member who was not involved in any of the phases of the clinical trial. The allocation assignment was revealed by opening the envelope on the day of the restorative procedure.The operator was not blinded to group assignment when administering.

The evaluations of the clinical performance of the restorations will be carried out by two previously calibrated examiners, adopting the criteria of the United States Public Health Service (USPHS) for the variables retention, marginal adaptation, marginal staining and postoperative sensitivity . The intragroup statistical analysis will be performed using the McNemar test for the variables retention and postoperative sensitivity; and by Wilcoxon for adaptation and marginal staining. To compare the clinical performance inter groups in the different assessment intervals, Fisher's exact test (retention and postoperative sensitivity) and Kruskal-Wallis (adaptation and marginal staining) will be used.

Being tested
Composite resin restoration with Self Etch adhesive protocol and absence of sclerotic dentin, Composite resin restoration with Seletive enamel etch adhesive protocol and absence of sclerotic dentin, Composite resin restoration with Self Etch adhesive protocol and presence of sclerotic dentin, Composite resin restoration with Seletive enamel etch adhesive protocol and presence of sclerotic dentin
Keywords
adhesives, dental bonding
Medical subject headings
Dentin, Secondary

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Composite resin restoration with Self Etch adhesive protocol and absence of sclerotic dentinProcedure or surgery

    The adhesive system Single Bond Universal (3M Oral Care; Brazil) and a nanoparticulate composite resin Z350 XT (3M Oral Care; Brazil), shade A3B, will be the materials used in the restorative procedures.

    For the D-SE group, the universal adhesive system will be applied with a disposable microbrush, actively, for 20s and then a gentle stream of air will be used for 5s to solvent evaporation, followed by light curing for 10s using the Valo Cordless light curing (Ultradent Products Inc.), in Standard mode (1000mW /cm2).

    All groups will receive the restorations made following the incremental technique of insertion of composite resin (2mm per increment), which will be light cured according to the manufacturer's recommendations.

  • Composite resin restoration with Seletive enamel etch adhesive protocol and absence of sclerotic dentinProcedure or surgery

    The adhesive system Single Bond Universal (3M Oral Care; Brazil) and a nanoparticulate composite resin Z350 XT (3M Oral Care; Brazil), shade A3B, will be the materials used in the restorative procedures.

    For the D-SELETIVE group a 37% phosphoric acid will be applied only at the enamel margin for 15s, then rinsed with water for 20s, and slightly dry. The universal adhesive system will be applied with a disposable microbrush, actively, for 20s and then a gentle stream of air will be used for 5s to solvent evaporation, followed by light curing for 10s using the Valo Cordless light curing (Ultradent Products Inc.), in Standard mode (1000mW /cm2).

    All groups will receive the restorations made following the incremental technique of insertion of composite resin (2mm per increment), which will be light cured according to the manufacturer's recommendations.

  • Composite resin restoration with Self Etch adhesive protocol and presence of sclerotic dentinProcedure or surgery

    The adhesive system Single Bond Universal (3M Oral Care; Brazil) and a nanoparticulate composite resin Z350 XT (3M Oral Care; Brazil), shade A3B, will be the materials used in the restorative procedures.

    For the SD-SE group, the universal adhesive system will be applied with a disposable microbrush, actively, for 20s and then a gentle stream of air will be used for 5s to solvent evaporation, followed by light curing for 10s using the Valo Cordless light curing (Ultradent Products Inc.), in Standard mode (1000mW /cm2).

    All groups will receive the restorations made following the incremental technique of insertion of composite resin (2mm per increment), which will be light cured according to the manufacturer's recommendations.

  • Composite resin restoration with Seletive enamel etch adhesive protocol and presence of sclerotic dentinProcedure or surgery

    The adhesive system Single Bond Universal (3M Oral Care; Brazil) and a nanoparticulate composite resin Z350 XT (3M Oral Care; Brazil), shade A3B, will be the materials used in the restorative procedures.

    For the SD-SELETIVE group a 37% phosphoric acid will be applied only at the enamel margin for 15s, then rinsed with water for 20s, and slightly dry. The universal adhesive system will be applied with a disposable microbrush, actively, for 20s and then a gentle stream of air will be used for 5s to solvent evaporation, followed by light curing for 10s using the Valo Cordless light curing (Ultradent Products Inc.), in Standard mode (1000mW /cm2).

    All groups will receive the restorations made following the incremental technique of insertion of composite resin (2mm per increment), which will be light cured according to the manufacturer's recommendations.

Study groups in NCT05211908
Study groupRoleWhat they receive
D-SEExperimentalAbsence of dentinal sclerosis and self-etching adhesive protocol
Receives: Procedure: Composite resin restoration with Self Etch adhesive protocol and absence of sclerotic dentin
D-SELETIVEActive comparatorAbsence of dentinal sclerosis and selective enamel etching adhesive protocol
Receives: Procedure: Composite resin restoration with Seletive enamel etch adhesive protocol and absence of sclerotic dentin
SD-SEExperimentalSclerotic dentin and self-etching adhesive protocol
Receives: Procedure: Composite resin restoration with Self Etch adhesive protocol and presence of sclerotic dentin
SD-SELETIVEExperimentalSclerotic dentin and selective enamel etching adhesive protocol
Receives: Procedure: Composite resin restoration with Seletive enamel etch adhesive protocol and presence of sclerotic dentin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Retention

    The restorations retention will be evaluated according to the criteria established by the United States Public Health Service (USPHS), classifying them in the following scores:

    Alpha - retained Bravo - partially retained Charlie - restoration lost For evaluation of clinical performance, beta and charlie scores will be considered as failure.

    Measured: 1 year

  2. Retention

    The restorations retention will be evaluated according to the criteria established by the United States Public Health Service (USPHS), classifying them in the following scores:

    Alpha - retained Bravo - partially retained Charlie - restoration lost For evaluation of clinical performance, beta and charlie scores will be considered as failure.

    Measured: 2 years

Secondary outcomes (4)
  1. Marginal adaptation

    Marginal adaptation will be evaluated according to the criteria established by the United States Public Health Service (USPHS), classifying them in the following scores:

    Alpha - Restoration is continuous with existing anatomic form. Bravo - Detectable V-shaped defect in enamel only. Catches explorer going both ways Charlie - Detectable V-shaped defect to dentin-enamel junction

    Measured: 1 year

  2. Marginal adaptation

    Marginal adaptation will be evaluated according to the criteria established by the United States Public Health Service (USPHS), classifying them in the following scores:

    Alpha - Restoration is continuous with existing anatomic form. Bravo - Detectable V-shaped defect in enamel only. Catches explorer going both ways Charlie - Detectable V-shaped defect to dentin-enamel junction

    Measured: 2 years

  3. Marginal staining

    Marginal staining will be evaluated according to the criteria established by the United States Public Health Service (USPHS), classifying them in the following scores:

    Alpha - No discoloration along the margin Bravo - Slight and superficial staining (removable, usually localized). Charlie - Deep staining cannot be polished away

    Measured: 1 Year

  4. Marginal staining

    Marginal staining will be evaluated according to the criteria established by the United States Public Health Service (USPHS), classifying them in the following scores:

    Alpha - No discoloration along the margin Bravo - Slight and superficial staining (removable, usually localized). Charlie - Deep staining cannot be polished away

    Measured: 2 Years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2022
  2. Study start27 Jul 2021
  3. Primary completion30 Mar 2022
  4. Study completion30 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05211908
Sponsor's protocol ID
UFPara-0013
Status last verified
May 2022
First submitted
13 Jan 2022
Last updated
19 May 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Composite resin restoration with Self Etch adhesive protocol and absence of sclerotic dentin, Composite resin restoration with Seletive enamel etch adhesive protocol and absence of sclerotic dentin and Composite resin restoration with Self Etch adhesive protocol and presence of sclerotic dentin in people with Sclerotic Dentine and Non Carious Cervical Lesion, run by Universidade Federal do Para at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Cecy M Silva, PhD ((91)3201-7563 ext. 55, cecymsilva@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Retention (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in